Contractility of Placental Vascular Smooth Muscle Cells in Response to Stimuli Produced by the Placenta: Roles of ACE Vs. Non-ACE and AT1 Vs. AT2 in Placental Vessel Cells

Overview

Journal Placenta

Publisher Elsevier

Specialties Gynecology & Obstetrics
Physiology
Reproductive Medicine

Date 2008 Apr 18

PMID 18417209

Citations 10

Authors

C Benoit

Y Gu

Y Zhang

J S Alexander

Y Wang

Affiliations

Soon will be listed here.

Abstract

Our previously published work has shown that non-ACE angiotensin II (Ang II) generating system is dominate in the placenta and may play a critical role in regulation of placental vascular contractile function. In the present study, using a collagen gel contraction assay we further studied contractility of placental vascular smooth muscle cells (VSMCs) in response to factors produced by preeclamptic (PE) placentas. Placental VSMCs/type-1 collagen gels were incubated with PE placental conditioned medium in the presence or absence of inhibitors or receptor blockers. Captopril (an ACE inhibitor), chymostatin (a non-ACE chymase inhibitor), losartan (an AT1 receptor blocker) and PD123,319 (an AT2 receptor blocker) were used to study the specific ACE vs. non-ACE and AT1 vs. AT2 effects on placental VSMC contractility, respectively. Our results showed that chymostatin, but not captopril, and PD123,319, but not losartan, significantly attenuated placental VSMC/collagen gel contraction, p<0.01, respectively. The inhibitory effects of chymostatin and PD123,319 were dose-dependent. Our results suggest that chymase, a non-ACE Ang II generating enzyme, may contribute significantly to Ang II generated in the placenta vascular tissue and that the AT2 receptor may play an important role in the regulation of Ang II induced contractility of placental VSMCs. These results provide new insights into Ang II generation and Ang II receptor regulation of vessel contractile function in the placental vasculature. These results also suggest the potential role of increased chymase activity and altered AT2 receptor function in placental related pregnancy disorders such as preeclampsia and IUGR.

Citing Articles

Pleiotropic Effects of Simvastatin and Losartan in Preclinical Models of Post-Traumatic Elbow Contracture.

David M, Reiter A, Dunham C, Castile R, Abraham J, Iannucci L Front Bioeng Biotechnol. 2022; 10:803403.

PMID: 35265595 PMC: 8899197. DOI: 10.3389/fbioe.2022.803403.

Omega-3 Fatty Acid-Derived Resolvin D2 Regulates Human Placental Vascular Smooth Muscle and Extravillous Trophoblast Activities.

Ulu A, Sahoo P, Yuil-Valdes A, Mukherjee M, Van Ormer M, Muthuraj P Int J Mol Sci. 2019; 20(18).

PMID: 31500240 PMC: 6770915. DOI: 10.3390/ijms20184402.

3D Printing for Bio-Synthetic Biliary Stents.

Boyer C, Boktor M, Samant H, White L, Wang Y, Ballard D Bioengineering (Basel). 2019; 6(1).

PMID: 30744131 PMC: 6466390. DOI: 10.3390/bioengineering6010016.

Renin-angiotensin system in pre-eclampsia: everything old is new again.

Spaan J, Brown M Obstet Med. 2019; 5(4):147-153.

PMID: 30705695 PMC: 6341511. DOI: 10.1258/om.2012.120007.

Functional and Proteomic Investigations Reveal Major Royal Jelly Protein 1 Associated with Anti-hypertension Activity in Mouse Vascular Smooth Muscle Cells.

Fan P, Han B, Feng M, Fang Y, Zhang L, Hu H Sci Rep. 2016; 6:30230.

PMID: 27444336 PMC: 4957218. DOI: 10.1038/srep30230.

References

Morgan T, Craven C, Ward K . Human spiral artery renin-angiotensin system. Hypertension. 1998; 32(4):683-7. DOI: 10.1161/01.hyp.32.4.683. View

Urata H, Kinoshita A, Misono K, BUMPUS F, Husain A . Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990; 265(36):22348-57. View

Urata H, Kinoshita A, Perez D, Misono K, BUMPUS F, Graham R . Cloning of the gene and cDNA for human heart chymase. J Biol Chem. 1991; 266(26):17173-9. View

Nakano A, Kishi F, Minami K, Wakabayashi H, Nakaya Y, Kido H . Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol. 1997; 159(4):1987-92. View

Walsh S . Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 1985; 152(3):335-40. DOI: 10.1016/s0002-9378(85)80223-4. View

Tom B, Garrelds I, Scalbert E, Stegmann A, Boomsma F, Saxena P . ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?. Arterioscler Thromb Vasc Biol. 2003; 23(2):251-6. DOI: 10.1161/01.atv.0000051875.41849.25. View

Iwai N, Matsunaga M, Kita T, Tei M, Kawai C . Regulation of renin-like enzyme in cultured human vascular smooth muscle cells. Jpn Circ J. 1988; 52(11):1338-45. DOI: 10.1253/jcj.52.1338. View

Taira H, Mizutani S, NARITA O, Tomoda Y . Angiotensin I-converting enzyme in human placenta. Placenta. 1985; 6(6):543-9. DOI: 10.1016/s0143-4004(85)80008-4. View

Dechend R, Viedt C, Muller D, Ugele B, Brandes R, Wallukat G . AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation. 2003; 107(12):1632-9. DOI: 10.1161/01.CIR.0000058200.90059.B1. View

10.

Le S, Wasserstrum N, Mombouli J, Vanhoutte P . Contractile effect of endothelin in human placental veins: role of endothelium prostaglandins and thromboxane. Am J Obstet Gynecol. 1993; 169(4):919-24. DOI: 10.1016/0002-9378(93)90027-g. View

11.

Li X, Shams M, Zhu J, Khalig A, Wilkes M, Whittle M . Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. J Clin Invest. 1998; 101(2):442-54. PMC: 508584. DOI: 10.1172/JCI119881. View

12.

Nielsen A, Winther H, Dantzer V, Poulsen K . High densities of angiotensin II subtype 2 (AT2) receptors in the porcine placenta and fetal membranes. Placenta. 1996; 17(2-3):147-53. DOI: 10.1016/s0143-4004(96)80007-5. View

13.

Kelley C, DAmore P, Hechtman H, Shepro D . Microvascular pericyte contractility in vitro: comparison with other cells of the vascular wall. J Cell Biol. 1987; 104(3):483-90. PMC: 2114529. DOI: 10.1083/jcb.104.3.483. View

14.

Wang Y, Gu Y, Philibert L, Lucas M . Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro. Placenta. 2001; 22(6):560-5. DOI: 10.1053/plac.2001.0691. View

15.

Watson S, Burnside T, Carver W . Angiotensin II-stimulated collagen gel contraction by heart fibroblasts: role of the AT1 receptor and tyrosine kinase activity. J Cell Physiol. 1998; 177(2):224-31. DOI: 10.1002/(SICI)1097-4652(199811)177:2<224::AID-JCP4>3.0.CO;2-P. View

16.

Urata H, Boehm K, Philip A, Kinoshita A, Gabrovsek J, BUMPUS F . Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest. 1993; 91(4):1269-81. PMC: 288095. DOI: 10.1172/JCI116325. View

17.

Wang Y, Gu Y, Zhang Y, Lewis D, Alexander J, Granger D . Increased chymotrypsin-like protease (chymase) expression and activity in placentas from women with preeclampsia. Placenta. 2006; 28(4):263-9. DOI: 10.1016/j.placenta.2006.03.012. View

18.

Walsh S, Wang Y . Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab. 1995; 80(6):1888-93. DOI: 10.1210/jcem.80.6.7775637. View

19.

Nickenig G, Harrison D . The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation. Circulation. 2002; 105(4):530-6. DOI: 10.1161/hc0402.102619. View

20.

Ivanov V, Roomi M, Kalinovsky T, Niedzwiecki A, Rath M . Natural nutrient mixture effectively reduces collagen matrix contraction driven by human uterine smooth muscle cells. J Obstet Gynaecol Res. 2006; 32(1):23-31. DOI: 10.1111/j.1447-0756.2006.00367.x. View